Effect of L-carnitine supplementation on resting metabolism rate and body composition in obese women

Effect of L-carnitine supplementation on resting metabolism rate and body composition in obese women, Double blinded control trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014042417408N1

Enrollment

Registered

2016-04-25

Start date

2014-07-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group: L - carnitine, 1 gram tablets, 2 times per day for 4 weeks. Intervention 2: Placebo group: Maltodextrin, 1-gram tablets, 2 times per day for 4 weeks.

Treatment - Drugs

Placebo

Intervention group: L - carnitine, 1 gram tablets, 2 times per day for 4 weeks

Placebo group: Maltodextrin, 1-gram tablets, 2 times per day for 4 weeks

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: obese women (BMI 30-35) who succeed to lose 10 to 15% of body weight in last 3-6 months under the supervision of qualified dietitian and proper diet and also have clear diet records and the specified file Exclusion criteria: Patients (cardiac, pulmonary, diabetes and thyroid disease), smokers or people with specific physiological conditions such as pregnancy, lactation and menopause, People who are taking multivitamin supplements and athletes are excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
BMI. Timepoint: beginning and end of study (4 weeks). Method of measurement: weight persons with a scale and height with a gauge and then put the results in equation of BMI (weight/height x Height).;Percent of body fat. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Body composition device.;Amount (kg) of body fat. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Weight persons with a scale and height with a gauge and then put the results in equation of BMI (weight/height x Height).;Amount of lean body mass. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Body composition device.;Waist to hip ratio. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Measure waist and hip size with a gauge and then use (waist/hip).;Weight. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Weight person with scale.	—

Measure

Time frame

BMI. Timepoint: beginning and end of study (4 weeks). Method of measurement: weight persons with a scale and height with a gauge and then put the results in equation of BMI (weight/height x Height).;Percent of body fat. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Body composition device.;Amount (kg) of body fat. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Weight persons with a scale and height with a gauge and then put the results in equation of BMI (weight/height x Height).;Amount of lean body mass. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Body composition device.;Waist to hip ratio. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Measure waist and hip size with a gauge and then use (waist/hip).;Weight. Timepoint: Beginning and end of study (4 weeks). Method of measurement: Weight person with scale.

—

Secondary

Measure	Time frame
Lipid profile. Timepoint: At the beginning and end of study. Method of measurement: Blood test.;Resting metabolism rate. Timepoint: At the beginning and end of study. Method of measurement: Indirect calorimetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJalal Moludi

Tehran University of Medical Sciences

jmoludi@yahoo.com+98 21 8897 4463

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026